SOURCE: BBK Worldwide

BBK Patient Recruitment and Engagement

May 27, 2015 09:00 ET

Diabetes Patient Advocacy Coalition (DPAC) Turns to BBK Worldwide for Brand Identity Development

BOSTON, MA--(Marketwired - May 27, 2015) - BBK Worldwide, a leading clinical trial marketing firm, has been chosen by the Diabetes Patient Advocacy Coalition (DPAC) to create the brand identity for the new not-for-profit organization. Selected for its longtime experience in and commitment to patient advocacy and engagement, BBK is developing the new corporate identity and brand to reflect the organization's commitment to focus lawmakers' attention on diabetes patients and their needs.

Founded earlier this year, DPAC is a non-partisan, not-for-profit organization established to amplify the diabetes patient voice to U.S. decision makers, understanding that those patient voices are critical to defining successful policy. Through a combination of lobbying and constituent awareness and education campaigns, DPAC's goals are to secure the safety and quality of care, medications, and devices needed for patients living with diabetes -- and the ability to access them.

"I am beyond grateful for the work done by BBK's creative team," said Christel Marchand Aprigliano, DPAC VP and co-founder. "They understood our charter right away, and presented design concepts that reflected our mission perfectly. We are excited for the future and thanks to BBK we can move forward with a brand that truly represents our goals and vision."

"We're pleased to be playing a role in helping DPAC raise its brand profile in a crowded diabetes market," said Matthew Stumm, BBK's Principal, Creative and Media Strategy. "With decades of experience in supporting diabetes research, we share an interest in improving the lives of diabetes patients and remain incredibly impressed with the work DPAC is doing for the diabetes community."

Next month, Christel will join BBK and The Michael J. Fox Foundation at the DIA 2015 Annual Meeting, June 14-18 in Washington, DC for a panel discussion titled, "Are You Patient Centric? Why Your Answer Must Be Yes." To be held on Monday, June 15 at 4:15 p.m., BBK Co-founder Bonnie A. Brescia will moderate what promises to be a thoughtful discussion on how a patient-centric approach can be employed not only to the benefit of patients but to the entire clinical trial process.

Additional Resources

About Diabetes Patient Advocacy Coalition
Created to unify over 28 million Americans with diabetes through simple and effective federal and state advocacy opportunities, the Diabetes Patient Advocacy Coalition works to highlight the areas of safety, quality, and access to care. Collaborating with other patient-centric organizations and companies, DPAC seeks to keep a consistent focus on diabetes policy for effective change. For more information about DPAC, please visit:

About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment and engagement for the clinical trial industry. BBK's innovative software solutions and consulting services leverage the company's adaptive recruitment methodology to protect global enrollment integrity, specifically within an ever-changing or threatened landscape. For more information, visit

Image Available:

Contact Information